From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development

From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley’s most influential VCs.

4 Comments

  1. dvolkman

    This is an exciting development in the AI drug development space! It’s impressive to see how Chai Discovery is making strides and gaining recognition. Partnerships like this can really push innovation forward.

  2. murray.halie

    Absolutely! Chai Discovery’s collaboration with Eli Lilly highlights the growing trend of integrating AI to streamline the drug discovery process. It will be interesting to see how their advancements could potentially reduce the time it takes to bring new treatments to market.

  3. alaina58

    You’re right! This partnership really showcases how AI is transforming not just drug development but the entire healthcare landscape. It’s fascinating to see how these advancements could lead to faster, more efficient treatments for patients.

  4. walter.tanner

    Absolutely! It’s fascinating to see how AI is streamlining the entire research process, potentially reducing the time it takes to bring new medications to market. This could lead to faster treatments for patients, which is an exciting prospect!

Leave a Reply to dvolkman Cancel reply

Your email address will not be published. Required fields are marked *